Trade Celon Pharma SA - CLNP CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.02
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentPLN 1,000.00Overnight funding adjustmentCharges from full value of position-0.02129 %(-PLN 1.06)Trade size with leverage ~ PLN 5,000.00Money from leverage ~ $PLN 4,000.00Go to platform: -0.02129%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentPLN 1,000.00Overnight funding adjustmentCharges from full value of position-0.00063 %(-PLN 0.03)Trade size with leverage ~ PLN 5,000.00Money from leverage ~ $PLN 4,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 22:00 (UTC)
• Currency: PLN
• Min traded quantity: 0.1
• Margin: 20.00%
• Stock exchange: Poland
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: PLN 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02129 %
  (-PLN 1.06)

• Margin. Your investment: PLN 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00063 %
  (-PLN 0.03)

Key Stats

• Prev. Close: 16.86
• Open: 16.86
• 1-Year Change: -21.58%
• Day's Range: 16.4 - 17.08

Trade Celon Pharma SA - CLNP

Celon Pharma S.A. (WSE: CLN) is an innovative Polish biopharmaceutical company focused on research, development, and production of proprietary therapies in oncology, psychiatry, and inflammatory diseases. With in-house R&D capabilities and a growing clinical pipeline, Celon aims to commercialize novel molecules for global markets. Its dual strategy of proprietary drug development and generic manufacturing ensures revenue diversification. The company offers investors exposure to high-potential biotech innovation anchored in local production and scientific expertise.